Don C Des-Jarlais

Summary

Affiliation: Beth Israel Medical Center
Country: USA

Publications

  1. pmc Use of the "NYC Condom" among people who use drugs
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY, USA
    J Urban Health 91:547-54. 2014
  2. pmc HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York, United States of America
    PLoS ONE 9:e87993. 2014
  3. pmc Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City
    D C Des Jarlais
    Beth Israel Medical Center, The Baron Edmond de Rothschild Chemical Dependency Institute, 160 Water Street, New York, NY, 10038, USA
    AIDS Behav 18:443-51. 2014
  4. pmc Transitions from injecting to non-injecting drug use: potential protection against HCV infection
    Don C Des Jarlais
    Don C Des Jarlais Beth Israel Medical Center, New York, NY 10038, USA Electronic address
    J Subst Abuse Treat 46:325-31. 2014
  5. pmc Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City, USA Electronic address
    Drug Alcohol Depend 132:S7-12. 2013
  6. pmc HIV infection among people who inject drugs: the challenge of racial/ethnic disparities
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Am Psychol 68:274-85. 2013
  7. pmc High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City, USA
    BMC Public Health 13:53. 2013
  8. pmc Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Addiction 107:2087-95. 2012
  9. pmc Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City 10038, USA
    Drug Alcohol Depend 124:95-107. 2012
  10. pmc Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York, United States of America
    PLoS ONE 7:e31227. 2012

Research Grants

  1. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2002
  2. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2002
  3. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2003
  4. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2003
  5. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 2003
  6. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2004
  7. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2005
  8. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2006
  9. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2005
  10. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2007

Detail Information

Publications102 found, 100 shown here

  1. pmc Use of the "NYC Condom" among people who use drugs
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY, USA
    J Urban Health 91:547-54. 2014
    ..Given the strong relationship between using the NYC Condom and consistent condom use, further efforts to promote the NYC Condom brand would be easily justified...
  2. pmc HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York, United States of America
    PLoS ONE 9:e87993. 2014
    ..To examine herpes simplex virus 2 (HSV-2)/HIV co-infection as a contributing factor in the increase in HIV infection among non-injecting heroin and cocaine users in New York City...
  3. pmc Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City
    D C Des Jarlais
    Beth Israel Medical Center, The Baron Edmond de Rothschild Chemical Dependency Institute, 160 Water Street, New York, NY, 10038, USA
    AIDS Behav 18:443-51. 2014
    ..Cumulative implementation of combined prevention programming for PWID was associated with substantial decreases in sexual risk behavior among HIV seropositives. ..
  4. pmc Transitions from injecting to non-injecting drug use: potential protection against HCV infection
    Don C Des Jarlais
    Don C Des Jarlais Beth Israel Medical Center, New York, NY 10038, USA Electronic address
    J Subst Abuse Treat 46:325-31. 2014
    ..New interventions to support transitions to non-injecting drug use should be developed and supported by both drug treatment and syringe exchange programs. ..
  5. pmc Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City, USA Electronic address
    Drug Alcohol Depend 132:S7-12. 2013
    ..We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide...
  6. pmc HIV infection among people who inject drugs: the challenge of racial/ethnic disparities
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Am Psychol 68:274-85. 2013
    ....
  7. pmc High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City, USA
    BMC Public Health 13:53. 2013
    ..However, we do not have a good understanding of the effectiveness of NSP in low/middle-income and transitional-economy countries...
  8. pmc Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Addiction 107:2087-95. 2012
    ..The Ethnic Minority Meta-Analysis (EMMA) aims to assess racial/ethnic disparities in HIV infection among people who inject drugs (PWID) across various countries. This is the first report of the data...
  9. pmc Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York City 10038, USA
    Drug Alcohol Depend 124:95-107. 2012
    ..There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed...
  10. pmc Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data
    Don C Des Jarlais
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York, United States of America
    PLoS ONE 7:e31227. 2012
    ..Many people who inject drugs (PWID) are sexually active, so it is possible that high-seroprevalence HIV epidemics among PWID may initiate self-sustaining heterosexual transmission epidemics...
  11. ncbi request reprint Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    AIDS Behav 11:78-84. 2007
    ..To assess variation in injection risk behavior among unstably housed/homeless injecting drug users (IDUs) across programs in a national sample of US syringe exchange programs...
  12. ncbi request reprint HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water Street 24th Floor, New York, NY 10038 USA
    Drug Alcohol Depend 109:154-60. 2010
    ..To identify potential behavioral mechanisms through which combined programs are effective...
  13. pmc HIV risk behaviors among female IDUs in developing and transitional countries
    Charles M Cleland
    Center for Drug Use and HIV Research, National Development and Research Institutes Inc, 71 West 23rd Street, New York, NY 10010, USA
    BMC Public Health 7:271. 2007
    ..Most data on gender differences come from industrialized countries, so data are needed in developing countries to determine how well gender differences generalize to these understudied regions...
  14. pmc The differential effects of face-to-face and computer interview modes
    Jessica Clark Newman
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    Am J Public Health 92:294-7. 2002
    ..This study assessed the differential effects of face-to-face interviewing and audio-computer assisted self-interviewing (audio-CASI) on categories of questions...
  15. ncbi request reprint "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001
    Don C Des Jarlais
    Beth Israel Medical Center and dagger National Development and Research Institutes, Inc, New York, NY, USA
    J Acquir Immune Defic Syndr 35:158-66. 2004
    ..To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world...
  16. doi request reprint Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, NewYork, NY 10038, USA
    Drug Alcohol Depend 101:88-91. 2009
    ..We examined the relationships between HCV and HIV and between HSV-2 and HIV among injecting drug users in New York City relative to the large-scale implementation of syringe exchange in the mid-1990s...
  17. ncbi request reprint Syringe exchange, injecting and intranasal drug use
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    Addiction 105:155-8. 2010
    ..The belief that implementation of syringe exchange will lead to increased drug injecting has been a persistent argument against syringe exchange...
  18. ncbi request reprint Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Epidemiol 157:467-71. 2003
    ..0/100 person-years) at the Lower East Side site. Results show that high rates of HBV and HCV transmission do not imply high rates of HIV transmission, even within an area of high HIV seroprevalence...
  19. ncbi request reprint The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
    Addiction 102:778-85. 2007
    ..To characterize heroin and cocaine users in New York City who have changed from injection to non-injection drug administration and to identify factors associated with long-term non-injection use...
  20. pmc Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    BMC Public Health 6:54. 2006
    ..We report on the development and implementation of the methodology underlying the survey component of the WHO Drug Injection Study Phase II--a multi-site study of risk behavior and HIV seroprevalence among Injecting Drug Users (IDUs)...
  21. ncbi request reprint Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    AIDS 19:S20-5. 2005
    ..The 1990-2001 time period included a very large expansion of syringe exchange in New York City, from 250,000 to 3,000,000 syringes exchanged annually...
  22. ncbi request reprint Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program
    Enrique R Pouget
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 39:471-7. 2005
    ....
  23. pmc HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services
    Don C Des Jarlais
    Beth Israel Medical Center, 1st Ave and 16th St, New York, NY 10003, USA
    Am J Public Health 95:1439-44. 2005
    ..Syringe exchange increased greatly during this period, from 250,000 to 3,000,000 syringes exchanged annually...
  24. pmc Respondent-driven sampling in a study of drug users in New York City: notes from the field
    Courtney McKnight
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    J Urban Health 83:i54-9. 2006
    ..RDS was efficient with respect to time and economics (we did not have to hire an outreach worker) and effective in recruiting a diverse sample of drug users...
  25. pmc The HCV Synthesis Project: scope, methodology, and preliminary results
    Rebecca K Stern
    Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    BMC Med Res Methodol 8:62. 2008
    ..The hepatitis C virus (HCV) is hyper-endemic in injecting drug users. There is also excess HCV among non-injection drug users who smoke, snort, or sniff heroin, cocaine, crack, or methamphetamine...
  26. ncbi request reprint Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs
    Theresa E Perlis
    National Development and Research Institutes, Inc, New York, NY 10003, USA
    Addiction 99:885-96. 2004
    ..A-CASI has been found to increase reporting of sensitive items among a variety of population subgroups...
  27. pmc Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug
    Barbara Tempalski
    National Development and Research Institutes, Inc, New York, NY, USA
    Int J Drug Policy 19:S47-58. 2008
    ..Notably, we know little about variations in syringe coverage within the U.S. and elsewhere, or about the social and political factors that might determine this coverage...
  28. ncbi request reprint Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 41:493-503. 2006
    ..To determine the incidence/predictors of transitions to injecting among noninjecting heroin users (NIUs)...
  29. ncbi request reprint Long-term effects of syringe exchange on risk behavior and HIV prevention
    Naomi Braine
    The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    AIDS Educ Prev 16:264-75. 2004
    ..This study confirms previous findings that SEPs can play a significant role in the prevention of HIV in marginal and impoverished communities in the United States...
  30. ncbi request reprint Hazardous drinking and HIV sexual risk behaviors among injection drug users in developing and transitional countries
    Kamyar Arasteh
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
    AIDS Behav 14:862-9. 2010
    ..These findings in the context of the high prevalence of drinking in many sites point to the importance of addressing alcohol use in HIV education and prevention policy for IDUs...
  31. ncbi request reprint HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs
    Naomi Braine
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA
    AIDS Educ Prev 17:515-24. 2005
    ..SEPs may need to develop new approaches to outreach and education to address the needs of amphetamine injectors and other populations at persistent risk...
  32. doi request reprint HIV testing and treatment among at-risk drinking injection drug users
    Kamyar Arasteh
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:196-201. 2009
    ..To test the hypothesis that at-risk drinking is associated with a smaller probability of prior HIV testing and access to antiretroviral treatment (ART) among injection drug users (IDUs) entering treatment for drug abuse...
  33. ncbi request reprint HIV prevention for injecting drug users: the first 25 years and counting
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York 10038, USA
    Psychosom Med 70:606-11. 2008
    ..Programs that provide these services need to be implemented on a public health scale for IDU populations at risk for HIV infection...
  34. pmc Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999
    Carey B Maslow
    National Development and Research Institutes, Inc, 71 West 23rd Street, New York, NY 10010, USA
    Am J Public Health 92:382-4. 2002
    ..This study examined HIV prevalence and risk behaviors among male injection drug users (IDUs) who have sex with men and among other male IDUs...
  35. ncbi request reprint Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    AIDS Educ Prev 19:111-23. 2007
    ....
  36. doi request reprint Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    AIDS 21:S109-14. 2007
    ..To assess an HIV prevention programme for injecting drug users (IDU) in the crossborder area between China and Vietnam...
  37. pmc Alcohol and HIV sexual risk behaviors among injection drug users
    Kamyar Arasteh
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, 160 Water Street, 24th Floor, New York, NY 10038, USA
    Drug Alcohol Depend 95:54-61. 2008
    ..These observations indicate both global and event-specific associations of alcohol and HIV sexual-risk behaviors...
  38. doi request reprint Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water St 24th Fl, New York, NY 10038, USA
    Am J Public Health 99:S445-51. 2009
    ..We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City...
  39. pmc At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City
    Kamyar Arasteh
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, New York 10038, USA
    AIDS Patient Care STDS 23:657-61. 2009
    ..These observations indicate that among HIV-positive IDUs at-risk drinking is associated with higher rates of injection and sexual risk behaviors and that alcohol intoxication is related to unprotected sex...
  40. pmc Role of sexual transmission of HIV among young noninjection and injection opiate users: a respondent-driven sampling study
    Jian Li
    Department of Epidemiology and Community Health, Virginia Commonwealth University, Richmond, VA, USA
    Sex Transm Dis 38:1161-6. 2011
    ..The objective of this study was to examine the role of sexual transmission on HIV infection among injection drug users (IDUs) and noninjection drug users (NIDUs)...
  41. pmc Public funding of US syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA
    J Urban Health 81:118-21. 2004
    ..In the absence of federal funding, state and local government support is associated with better syringe exchange performance...
  42. ncbi request reprint Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    Int J Drug Policy 18:475-85. 2007
    ..Here, we determine which metropolitan area characteristics are associated with drug treatment coverage...
  43. ncbi request reprint Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Infect Dis 195:1052-61. 2007
    ..Many heroin users do not inject drugs but may still be at risk of infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV), via sexual or other noninjection-related activity...
  44. pmc The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units
    Shiela M Strauss
    National Development and Research Institutes Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 81:38-47. 2004
    ..Drug treatment programs need to educate patients about the proactive steps these individuals can take to deal with HCV, provide critically needed HCV services, and encourage patients to make full use of these services...
  45. pmc Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, USA
    BMC Public Health 5:89. 2005
    ..To assess patterns of injecting drug use and HIV prevalence among injecting drug users (IDUs) in an international border area along a major heroin trans-shipment route...
  46. ncbi request reprint Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users
    Benny J Kottiri
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, New York, USA
    J Acquir Immune Defic Syndr 30:95-104. 2002
    ..In Bushwick, racially/ethnically discordant risk partnerships involving black IDUs may function as potential bridges of transmission between groups...
  47. ncbi request reprint Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    AIDS 21:231-5. 2007
    ..As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users...
  48. ncbi request reprint Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S
    Shiela M Strauss
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    Drug Alcohol Depend 83:15-24. 2006
    ..Similar analyses in other countries can inform their policy makers about the capacity of their drug treatment programs to provide support to their HCV infected patients...
  49. pmc HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women
    Samuel R Friedman
    National Development and Research Institutes Inc, New York, NY 10010, USA
    Am J Public Health 93:902-6. 2003
  50. pmc Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing
    David C Perlman
    Department of Medicine, Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, New York 10003, USA
    J Urban Health 80:428-37. 2003
    ..Previous cost modeling demonstrated that a monetary incentive to promote adherence could be justified on the cost basis if it had even a modest effect on adherence...
  51. ncbi request reprint Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectives
    Shiela M Strauss
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, New York 10010, USA
    Subst Use Misuse 40:1811-29. 2005
    ..Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns...
  52. ncbi request reprint Reducing syringe sharing among injecting drug users in Winnipeg: 81% success or 19% failure?
    Don Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, USA
    Addiction 102:1636. 2007
  53. ncbi request reprint Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23rd Street, New York, NY 10010, USA
    Addiction 98:159-69. 2003
    ..Drug users, particularly injection drug users and crack smokers, may be a core group for some sexually transmitted infections...
  54. ncbi request reprint Provision of hepatitis C education in a nationwide sample of drug treatment programs
    Janetta Astone
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Drug Educ 33:107-17. 2003
    ..Our findings indicate that there is a need to increase HCV educational services in drug treatment programs...
  55. pmc Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23d Street, 8th Floor, New York, NY 10010, USA
    BMC Public Health 8:94. 2008
    ..Prevalence rates for long-term injection drug users in some localities surpass 60% for HIV and 80% for HCV. We describe methods for developing grounded hypotheses about how some injectors avoid infection with either virus...
  56. pmc Data and public health decision making on HIV prevention in injection drug users
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY, USA
    J Urban Health 85:303-5. 2008
  57. ncbi request reprint Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services
    Janetta M Astone
    National Development and Research Institutes, Inc, 71 West 23rd St, 8th Floor, New York, NY 10010, USA
    Am J Drug Alcohol Abuse 30:783-97. 2004
    ..Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication...
  58. ncbi request reprint Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    AIDS 20:93-9. 2006
    ..To understand associations of punitive policies to the population prevalence of injection drug users and to HIV seroprevalence among injectors...
  59. ncbi request reprint HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institute, New York, NY 10010, USA
    AIDS 19:S199-207. 2005
    ....
  60. ncbi request reprint Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institutes, New York, New York 10010, USA
    Epidemiology 15:543-9. 2004
    ....
  61. pmc Diffusion of the D.A.R.E and syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    Am J Public Health 96:1354-8. 2006
    ..The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations...
  62. pmc Social factors associated with AIDS and SARS
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water Street, 24th Floor, New York, NY 10038, USA
    Emerg Infect Dis 11:1767-9. 2005
    ..We conducted a survey of 928 New York City area residents to assess knowledge and worry about AIDS and SARS. Specific sociodemographic groups of persons were more likely to be less informed and more worried about contracting the diseases...
  63. ncbi request reprint Mathilde Krim, amfAR, and the prevention of HIV infection among injecting drug users: a brief history
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency, Beth Israel Medical Center, New York, New York, USA
    AIDS Patient Care STDS 20:467-71. 2006
  64. pmc Perceptions of drug users regarding hepatitis C screening and care: a qualitative study
    Ashly E Jordan
    Beth Israel Medical Center, 120 East 16th St, New York, NY 10003, USA
    Harm Reduct J 10:10. 2013
    ..Racial and ethnic minorities have a higher incidence and prevalence of HCV and higher HCV-related mortality. Factors contributing to poor engagement in care are incompletely understood...
  65. ncbi request reprint Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City
    Crystal M Fuller
    Center for Infectious Disease Epidemiologic Research, Columbia University, Mailman School of Public Health, New York, NY 10032, USA
    Ethn Dis 14:589-96. 2004
    ..The purpose of this study was to assess the factors that could explain the relationship between race/ethnicity and pharmacy use...
  66. ncbi request reprint Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS)
    Wen Hung Kuo
    State University of New York Downstate Medical Center, Brooklyn, New York, USA
    AIDS Patient Care STDS 18:702-13. 2004
    ..001, RH = 0.24). In summary, among HIV-infected women, the incidence of weekly marijuana use was associated with only one marker of HIV disease stage and HAART was associated with lower initiation rate of weekly marijuana use...
  67. doi request reprint Doing harm reduction better: syringe exchange in the United States
    Don C Des Jarlais
    Beth Israel Medical Center, 160Water Street 24th Floor, NewYork, NY 10038, USA
    Addiction 104:1441-6. 2009
    ..To trace the growth of syringe exchange programs (SEPs) in the United States since 1994-95 and assess the current state of SEPs...
  68. doi request reprint HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water Street, 24th Floor, New York, NY 10038, USA
    Curr Opin HIV AIDS 4:308-13. 2009
    ..To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs)...
  69. ncbi request reprint Gaps in the drug-free and methadone treatment program response to Hepatitis C
    Shiela M Strauss
    National Development and Research Institutes, Inc, 71 West 23 Street, 8th Floor, 10010, New York, NY, USA
    J Subst Abuse Treat 24:291-7. 2003
    ..Managers of drug-free programs would like to be offering patients more HCV education, while MMTP managers would like to be providing more HCV testing to their patients, and more support and care for patients who are HCV+...
  70. pmc Updating the infection risk reduction hierarchy: preventing transition into injection
    David Vlahov
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
    J Urban Health 81:14-9. 2004
    ....
  71. ncbi request reprint Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institutes, New York, New York 10010, USA
    Clin Infect Dis 40:S297-303. 2005
    ..05). With high dropout rates in the early stages of treatment for drug addiction, these medical visits may be an important opportunity for further monitoring and care for HCV infection and other conditions...
  72. ncbi request reprint Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    J Am Pharm Assoc (Wash) 42:S73-6. 2002
    ..To assess preliminary results of the Expanded Syringe Access Demonstration Program (ESAP) in New York City...
  73. ncbi request reprint The use of electronic debit cards in longitudinal data collection with geographically mobile drug users
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, 1st Avenue at 16th Street, New York, NY 10003, USA
    Drug Alcohol Depend 77:1-5. 2005
    ..To assess the use of electronic debit (ATM) cards in conducting longitudinal research with geographically mobile ("urban nomad") drug users...
  74. ncbi request reprint Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs
    Zdravko P Vassilev
    National Development and Research Institutes Inc, 71 W 23 St 8th floor, New York, NY 10010, USA
    J Behav Health Serv Res 31:208-16. 2004
    ....
  75. ncbi request reprint Knowledge of hepatitis among active drug injectors at a syringe exchange program
    Jeanne Carey
    Department of Medicine, Beth Israel Medical Center, New York, NY 10003, USA
    J Subst Abuse Treat 29:47-53. 2005
    ..Stronger linkages between health-care centers and SEPs, drug treatment programs, and other service delivery centers where IDUs are encountered may promote hepatitis education and vaccination...
  76. ncbi request reprint Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs
    Corrine E Munoz-Plaza
    STOP HEP C Project, New York, NY, USA
    J Psychoactive Drugs 38:233-41. 2006
    ..While programs need more funding and resources to overcome these barriers, these findings may prove helpful to other drug treatment programs that would like to offer HCV services to at least some of their clients...
  77. pmc Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
    Russell Rockwell
    National Development and Research Institutes, Inc, New York, New York, USA
    J Urban Health 79:136-46. 2002
    ..Enhancing access to services for IDUs in the boroughs outside Manhattan may be needed to continue the positive trends in all areas of New York City...
  78. pmc Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas
    Barbara Tempalski
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 97:437-47. 2007
    ..Need was not a predictor...
  79. ncbi request reprint Herpes simplex virus-2 and HIV among noninjecting drug users in New York city
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Sex Transm Dis 34:923-7. 2007
    ..To examine the relationship between herpes simplex virus 2 (HSV-2) seroprevalence and human immunodeficiency virus (HIV) seroprevalence among noninjecting heroin and cocaine users in New York City...
  80. pmc Stigmatization of newly emerging infectious diseases: AIDS and SARS
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water St, 24th Floor, New York, NY 10038, USA
    Am J Public Health 96:561-7. 2006
    ..We assessed relationships between sociodemographic characteristics and mental health status and knowledge of, being worried about, and stigmatization of 2 emerging infectious diseases: AIDS and SARS...
  81. ncbi request reprint Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program
    Charles M Cleland
    National Development and Research Institutes NDRI, New York, New York 10010, USA org
    Health Educ Behav 34:390-403. 2007
    ..More detailed information on disposal practices is needed to capture the continuum from least to most safe practices and variation within individuals...
  82. ncbi request reprint Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users
    V Anna Gyarmathy
    National Development and Research Institutes, Inc, New York City, New York 10010, USA
    J Acquir Immune Defic Syndr 30:448-56. 2002
    ..To examine lifetime correlates of HIV and hepatitis B and C (HBV and HCV) infections among noninjecting heroin users (NIUs)...
  83. ncbi request reprint Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?
    Farzana Kapadia
    Center for Urban Epidemiologic Studies, New York Academy of Medicine, NY 10029, USA
    Epidemiology 13:738-41. 2002
    ..Hepatitis C virus (HCV) has emerged as a major public health problem among injection drug users. In this analysis we examine whether disinfection of syringes with bleach has a potentially protective effect on anti-HCV seroconversion...
  84. ncbi request reprint Assessing syringe exchange programs
    Don C Des Jarlais
    Addiction 99:1081-2. 2004
  85. ncbi request reprint Incarceration and risk for HIV infection among injection drug users in Bangkok
    Kachit Choopanya
    Bangkok Metropolitan Administration, Bangkok, Thailand
    J Acquir Immune Defic Syndr 29:86-94. 2002
    ..Previous cross-sectional studies have shown strong relationships between incarceration and HIV infection but have not been able to assess potential causal pathways...
  86. ncbi request reprint Opiate agonist maintenance treatment for injecting drug user peer educators
    Don C Des Jarlais
    Addiction 99:1355-6. 2004
  87. ncbi request reprint Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand
    Suphak Vanichseni
    Bangkok Metropolitan Administration, Bangkok, Thailand
    J Acquir Immune Defic Syndr 37:1170-9. 2004
    ..This study assessed whether long-term participation in interventions to reduce sexual risk behavior was associated with reduced sexual risk behavior...
  88. ncbi request reprint HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand
    Kachit Choopanya
    Bangkok Metropolitan Administration, Bangkok, Thailand
    J Acquir Immune Defic Syndr 33:88-95. 2003
    ..To determine changes in risk behavior in relation to study participation among injecting drug users (IDUs) in Bangkok, Thailand...
  89. pmc Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes Inc, 71 West 23rd Street, New York City, NY 10010, USA
    Drug Alcohol Depend 89:234-43. 2007
    ..Early interventions, targeting injecting and sexual risks and including HBV vaccination, are needed among new IDUs to prevent HBV, HCV and, potentially, HIV epidemics...
  90. pmc Non-injection drug use and Hepatitis C Virus: a systematic review
    Roberta Scheinmann
    Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, United States
    Drug Alcohol Depend 89:1-12. 2007
    ..These studies point to a real problem of HCV in NIDU populations, but the causal pathway to infection remains unclear...
  91. pmc Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups
    Samuel R Friedman
    National Development and Research Institutes, Inc, New York, NY, United States
    Int J Drug Policy 18:107-17. 2007
    ..Finally, both researchers and policy makers should help develop ways to enable and support both micro-social and formally organized action by users...
  92. ncbi request reprint HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection
    Holly Hagan
    Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, New York, NY 10010, United States
    Int J Drug Policy 18:341-51. 2007
    ..This will permit synthesis of a greater number of studies and may lead to the identification of factors that impede HCV transmission...
  93. pmc Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study
    Abu S Abdul-Quader
    Behavioral and Clinical Surveillance Branch, Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    J Urban Health 83:459-76. 2006
    ..The findings indicate that RDS is an effective sampling method for recruiting diversified drug users to participate in HIV-related behavioral surveys...
  94. ncbi request reprint 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam
    Theodore M Hammett
    Abt Associates Inc, Cambridge, MA 02138 1168, USA
    Addiction 103:137-45. 2008
    ..This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment...
  95. ncbi request reprint The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings
    Sherry Deren
    Center for Drug Use and HIV Research, Institute for AIDS Research, NDRI, New York 10010, USA
    AIDS Behav 10:717-21. 2006
    ..The findings indicate that providing multiple sources of safe syringes for IDUs is necessary...
  96. pmc Effects of behavioral intervention on substance use among people living with HIV: the Healthy Living Project randomized controlled study
    F Lennie Wong
    University of California, Los Angeles, CA, USA
    Addiction 103:1206-14. 2008
    ..Reductions in substance use were examined in response to an intensive intervention with people living with human immunodeficiency virus (HIV) (PLH)...
  97. pmc Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities
    Richard S Garfein
    Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Urban Health 81:260-7. 2004
    ..Prevention efforts are needed on the West Coast to decrease HIV-associated risk behaviors among IDUs, and further efforts are also needed to reduce HIV incidence on the East Coast...
  98. pmc Behavior change and health-related interventions for heterosexual risk reduction among drug users
    Salaam Semaan
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Subst Use Misuse 41:1349-78. 2006
    ..It is important to adapt effective interventions implemented in resource-rich countries to the realities of the resource-constrained settings and to address relevant contextual factors...
  99. ncbi request reprint Association between injection practices and duration of injection among recently initiated injection drug users
    Meredith Becker Buxton
    Center for Urban Epidemiological Studies, New York Academy of Medicine, New York City, NY 10029 5293, USA
    Drug Alcohol Depend 75:177-83. 2004
    ..Whether IDUs' risky injection practices rise progressively with duration of injection or frequency of practices is higher near initiation and then taper remains an open question...

Research Grants38

  1. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2002
    ..abstract_text> ..
  2. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2002
    ..abstract_text> ..
  3. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2003
    ..abstract_text> ..
  4. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2003
    ..abstract_text> ..
  5. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 2003
    ..The information obtained in the research should be useful for both HIV prevention planning in the US as well as understanding persistent risk behavior among persons already participating in prevention programs. ..
  6. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2004
    ....
  7. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2005
    ....
  8. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2006
    ....
  9. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2005
    ....
  10. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 2007
    ....
  11. HIV Infection in Ethnic Minority IDUs: An International Systematic Review
    Don Des Jarlais; Fiscal Year: 2009
    ..An international systematic review and meta-analysis should greatly advance our understanding of these disparities and suggest how they might be ameliorated. ..
  12. Multiple HIV Prevention Packages for IDUs in Estonia
    Don Des Jarlais; Fiscal Year: 2009
    ..These inter-related problems are an ideal context for studying the effects of combined HIV prevention programs. ..
  13. Risk Factors for HIV/AIDS in Drug Users
    Don Des Jarlais; Fiscal Year: 2009
    ..This study will generate an in-depth understanding of the largest HIV epidemic among NIDUs in the US. ..
  14. Risk Factors for HIV/AIDS in Drug Users
    Don C Des Jarlais; Fiscal Year: 2010
    ..This study will generate an in-depth understanding of the largest HIV epidemic among NIDUs in the US. ..
  15. Multiple HIV Prevention Packages for IDUs in Estonia
    Don C Des Jarlais; Fiscal Year: 2010
    ..These inter-related problems are an ideal context for studying the effects of combined HIV prevention programs. ..
  16. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2002
    ..abstract_text> ..
  17. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 2002
    ..The information obtained in the research should be useful for both HIV prevention planning in the US as well as understanding persistent risk behavior among persons already participating in prevention programs. ..
  18. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 1999
    ..The information obtained in the research should be useful for both HIV prevention planning in the US as well as understanding persistent risk behavior among persons already participating in prevention programs. ..
  19. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 1999
    ..abstract_text> ..
  20. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 1991
    ..and drug-related policies and prevention programs in these cities)...
  21. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 1992
    ..and drug-related policies and prevention programs in these cities)...
  22. RISK FACTORS FOR AIDS AMONG INTRAVENOUS DRUG USERS
    Don Des Jarlais; Fiscal Year: 1993
    ..and drug-related policies and prevention programs in these cities)...
  23. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 2000
    ..The information obtained in the research should be useful for both HIV prevention planning in the US as well as understanding persistent risk behavior among persons already participating in prevention programs. ..
  24. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2000
    ..abstract_text> ..
  25. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2000
    ..abstract_text> ..
  26. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 2000
    ..The information obtained in the research should be useful for both HIV prevention planning in the US as well as understanding persistent risk behavior among persons already participating in prevention programs. ..
  27. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2001
    ..abstract_text> ..
  28. NATIONAL STUDY OF SYRINGE EXCHANGE PROGRAMS
    Don Des Jarlais; Fiscal Year: 2001
    ..The information obtained in the research should be useful for both HIV prevention planning in the US as well as understanding persistent risk behavior among persons already participating in prevention programs. ..
  29. HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
    Don Des Jarlais; Fiscal Year: 2001
    ..abstract_text> ..
  30. RISK FACTORS FOR AIDS AMONG IV DRUG USERS
    Don Des Jarlais; Fiscal Year: 2002
    ..abstract_text> ..
  31. HIV Infection in Ethnic Minority IDUs: An International Systematic Review
    Don C Des Jarlais; Fiscal Year: 2010
    ..An international systematic review and meta-analysis should greatly advance our understanding of these disparities and suggest how they might be ameliorated. ..